
Digital twin modeling plus metabolomics predicts which drugs can starve glioblastoma, enabling faster, personalized treatment testing.
Baharan Meghadid, PhD, is a researcher in the Department of Chemical Engineering at the University of Michigan.

Digital twin modeling plus metabolomics predicts which drugs can starve glioblastoma, enabling faster, personalized treatment testing.